MediciNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MediciNova and other ETFs, options, and stocks.

About MNOV

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. 

CEO
Yuichi Iwaki
CEOYuichi Iwaki
Employees
6
Employees6
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2000
Founded2000
Employees
6
Employees6

MNOV Key Statistics

Market cap
72.36M
Market cap72.36M
Price-Earnings ratio
-5.97
Price-Earnings ratio-5.97
Dividend yield
Dividend yield
Average volume
90.81K
Average volume90.81K
High today
$1.47
High today$1.47
Low today
$1.44
Low today$1.44
Open price
$1.45
Open price$1.45
Volume
45.80K
Volume45.80K
52 Week high
$1.96
52 Week high$1.96
52 Week low
$1.13
52 Week low$1.13

Stock Snapshot

As of today, MediciNova(MNOV) shares are valued at $1.46. The company's market cap stands at 72.36M, with a P/E ratio of -5.97.

On 2026-03-25, MediciNova(MNOV) stock traded between a low of $1.44 and a high of $1.47. Shares are currently priced at $1.46, which is +1.4% above the low and -0.9% below the high.

The MediciNova(MNOV)'s current trading volume is 45.8K, compared to an average daily volume of 90.81K.

In the last year, MediciNova(MNOV) shares hit a 52-week high of $1.96 and a 52-week low of $1.13.

In the last year, MediciNova(MNOV) shares hit a 52-week high of $1.96 and a 52-week low of $1.13.

MNOV News

TipRanks 3d
Maxim resumes MediciNova at Buy on potential value-driving data events this year

Maxim analyst Michael Okunewitch resumed coverage of MediciNova (MNOV) with a Buy rating and $6 price target The firm is positive on the company’s potential val...

TipRanks 3d
MediciNova resumed with a Buy at Maxim

Maxim resumed coverage of MediciNova (MNOV) with a Buy rating and $6 price target Published first on TheFly – the ultimate source for real-time, market-moving...

People also own

Based on the portfolios of people who own MNOV. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.